ES2101079T3 - Marcadores analiticos para el cancer, principalmente para el cancer de seno. - Google Patents

Marcadores analiticos para el cancer, principalmente para el cancer de seno.

Info

Publication number
ES2101079T3
ES2101079T3 ES92901155T ES92901155T ES2101079T3 ES 2101079 T3 ES2101079 T3 ES 2101079T3 ES 92901155 T ES92901155 T ES 92901155T ES 92901155 T ES92901155 T ES 92901155T ES 2101079 T3 ES2101079 T3 ES 2101079T3
Authority
ES
Spain
Prior art keywords
cancer
mainly
breast cancer
understands
analytical markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92901155T
Other languages
English (en)
Spanish (es)
Inventor
Paul Basset
Jean-Pierre Bellocq
Pierre Chambon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Application granted granted Critical
Publication of ES2101079T3 publication Critical patent/ES2101079T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
ES92901155T 1990-11-21 1991-11-21 Marcadores analiticos para el cancer, principalmente para el cancer de seno. Expired - Lifetime ES2101079T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9025326A GB2250993B (en) 1990-11-21 1990-11-21 Stromelysin-3 and its application in the diagnosis and treatment of malignant breast cancer

Publications (1)

Publication Number Publication Date
ES2101079T3 true ES2101079T3 (es) 1997-07-01

Family

ID=10685753

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92901155T Expired - Lifetime ES2101079T3 (es) 1990-11-21 1991-11-21 Marcadores analiticos para el cancer, principalmente para el cancer de seno.

Country Status (16)

Country Link
US (1) US5236844A (ja)
EP (1) EP0513316B1 (ja)
JP (1) JP3516448B2 (ja)
AT (1) ATE152179T1 (ja)
CA (1) CA2073860A1 (ja)
DE (1) DE69125824T2 (ja)
DK (1) DK0513316T3 (ja)
ES (1) ES2101079T3 (ja)
GB (1) GB2250993B (ja)
GR (1) GR3023560T3 (ja)
HU (1) HU215165B (ja)
IE (1) IE914056A1 (ja)
NZ (2) NZ260705A (ja)
PT (1) PT99562B (ja)
WO (1) WO1992009701A1 (ja)
ZA (1) ZA919219B (ja)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012645A2 (en) * 1992-11-25 1994-06-09 University Of Pittsburgh Of The Commonwealth System Of Higher Education cDNA CLONE FOR HUMAN INDUCIBLE NITRIC OXYDE SYNTHASE AND PROCESS FOR PREPARING SAME
EP0712444A1 (en) * 1993-07-20 1996-05-22 University Of Massachusetts Medical Center In vivo nucleic acid hybridization method
JPH07303482A (ja) 1993-11-30 1995-11-21 Fuji Yakuhin Kogyo Kk 新規なメタロプロテアーゼおよびそれをコードするｄｎａ
EP0685557B1 (en) * 1993-11-30 1998-08-12 Fuji Yakuhin Kogyo Kabushiki Kaisha Novel metalloprotease and dna coding for the same
US6825024B1 (en) 1993-11-30 2004-11-30 Fuji Yakuhin Kogyo Kabushiki Kaisha Metalloproteinase and encoding DNA therefor
US5709999A (en) * 1994-08-12 1998-01-20 Myriad Genetics Inc. Linked breast and ovarian cancer susceptibility gene
US5747282A (en) * 1994-08-12 1998-05-05 Myraid Genetics, Inc. 17Q-linked breast and ovarian cancer susceptibility gene
US5753441A (en) * 1994-08-12 1998-05-19 Myriad Genetics, Inc. 170-linked breast and ovarian cancer susceptibility gene
US5710001A (en) * 1994-08-12 1998-01-20 Myriad Genetics, Inc. 17q-linked breast and ovarian cancer susceptibility gene
US5763415A (en) * 1995-08-03 1998-06-09 John Hopkins University School Of Medicine Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
WO1997009420A2 (en) * 1995-09-05 1997-03-13 Celltech Therapeutics Limited Dna sequences coding for a human metalloproteinase and variants thereof
US5905027A (en) * 1995-12-27 1999-05-18 Uab Research Foundation Method of diagnosing and treating gliomas
CA2252509A1 (en) * 1996-04-25 1997-10-30 Takeda Chemical Industries, Ltd. Matrix metalloprotease
EP0939824B1 (en) * 1996-10-31 2007-06-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US20050153373A1 (en) * 1996-10-31 2005-07-14 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US20030165971A1 (en) * 1996-10-31 2003-09-04 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
AU722819B2 (en) * 1996-12-06 2000-08-10 Urocor, Inc. Diagnosis of disease state using mRNA profiles
WO1998040475A1 (en) * 1997-03-11 1998-09-17 Abbott Laboratories Human matrix metalloprotease gene, proteins encoded therefrom and methods of using same
JP4427106B2 (ja) 1997-03-18 2010-03-03 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 平滑筋腫を治療および診断するための方法およびキット
US7332270B1 (en) 1997-03-24 2008-02-19 Urocor, Inc. Diagnosis of disease state using mRNA profiles in peripheral leukocytes
US6190857B1 (en) 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
US20040072210A1 (en) * 1997-07-07 2004-04-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
WO1999002714A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999025850A1 (en) * 1997-11-17 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US5972615A (en) * 1998-01-21 1999-10-26 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US7041787B2 (en) * 2000-12-29 2006-05-09 Kimberly-Clark Worldwide, Inc. Design and use of advanced zinc chelating peptides to regulate matrix metalloproteinases
US6600057B2 (en) 2000-12-29 2003-07-29 Kimberly-Clark Worldwide, Inc. Matrix metalloproteinase inhibitors
US20040219551A1 (en) * 2001-07-09 2004-11-04 Petersen Ole William Epsti1, a novel gene induced by epithelial-stromal interaction in human breast cancer
US20030119073A1 (en) * 2001-12-21 2003-06-26 Stephen Quirk Sensors and methods of detection for proteinase enzymes
DE10217254A1 (de) * 2002-04-15 2003-10-23 Proteosys Ag Verwendung von Substanzen zur Behandlung von Tumoren
US20060088899A1 (en) * 2002-05-31 2006-04-27 Alvarez Vernon L Combination chemotherapy with chlorotoxin
US20050193432A1 (en) * 2003-11-18 2005-09-01 Whitehead Institute For Biomedical Research Xenograft model of functional normal and malignant human breast tissues in rodents and methods thereof
US7569662B2 (en) * 2004-01-27 2009-08-04 Compugen Ltd Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US7667001B1 (en) * 2004-01-27 2010-02-23 Compugen Ltd. Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
US20090191543A1 (en) * 2005-05-27 2009-07-30 Theregents Of The University Of California Identification of rac1b as a marker and mediator of metalloproteinase-induced malignancy
JP2011520914A (ja) 2008-05-15 2011-07-21 トランスモレキュラー， インコーポレイテッド 転移腫瘍の処置
CN102844044B (zh) 2010-02-04 2016-10-26 摩尔弗泰克有限公司 氯毒素多肽和结合物及其应用
JP2013532126A (ja) 2010-05-11 2013-08-15 フレッド ハッチンソン キャンサー リサーチ センター クロロトキシン変異体、コンジュゲート、およびそれらを使用する方法
KR101313184B1 (ko) * 2010-06-24 2013-09-30 한국표준과학연구원 질병 지표 검출 키트 및 질병 지표 검출 방법
RU2015126651A (ru) 2012-12-10 2017-01-16 Фред Хатчинсон Кэнсер Рисёрч Сентер Способы скрининга
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007907A1 (en) * 1986-06-17 1987-12-30 Celltech Limited Process for the production of a protein

Also Published As

Publication number Publication date
PT99562B (pt) 1999-04-30
GR3023560T3 (en) 1997-08-29
HU9202368D0 (en) 1992-10-28
DK0513316T3 (da) 1997-05-20
HUT65373A (en) 1994-05-02
EP0513316A1 (fr) 1992-11-19
NZ240688A (en) 1994-09-27
DE69125824T2 (de) 1997-08-07
WO1992009701A1 (fr) 1992-06-11
AU9089691A (en) 1992-06-25
US5236844A (en) 1993-08-17
ATE152179T1 (de) 1997-05-15
JP3516448B2 (ja) 2004-04-05
AU646914B2 (en) 1994-03-10
NZ260705A (en) 1997-05-26
HU215165B (hu) 1998-10-28
GB2250993A (en) 1992-06-24
GB9025326D0 (en) 1991-01-02
ZA919219B (en) 1992-10-28
PT99562A (pt) 1992-10-30
JPH05505530A (ja) 1993-08-19
EP0513316B1 (fr) 1997-04-23
GB2250993B (en) 1995-02-15
CA2073860A1 (en) 1992-05-22
DE69125824D1 (de) 1997-05-28
IE914056A1 (en) 1992-06-03

Similar Documents

Publication Publication Date Title
ES2101079T3 (es) Marcadores analiticos para el cancer, principalmente para el cancer de seno.
HRP20130707T1 (en) Compositions and uses for treating multiple sclerosis
CL2021001490A1 (es) Constructos de iarn modificados químicamente y usos de estos
SV1999000047A (es) Nuevas dihidropirimidinas fef. lea 32792-sv
AR019175A1 (es) Acero de cementacion a temperatura de revenido elevada, procedimiento de fabricacion de piezas cementadas y tratadas de dicho acero y piezas formadas con ese acero.
UY28680A1 (es) Fenilalanina-amidas sustituidas por heteroaroilo .
AR030816A1 (es) Derivados de glucopiranosiloxibencilbenceno y composiciones farmaceuticas que comprenden los mismos
BR112012009053A2 (pt) derivado de glicosídeos e usos do mesmo
BR0210711A (pt) Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto
UY26456A1 (es) Compuestos que fijan la estructura g-cuadruplex de los telomeros, triazinas de aplicación de dichos compuestos, la utilización de dichos compuestos como productos farmacéuticos y las asociaciones terapéuticas que los incluyen.
BR112013012795B8 (pt) processo de tratamento de produtos vegetais e composição
BR112012018343A2 (pt) "composições imunogênicas"
MX9307232A (es) Arilcicloalquilaminas n,n-disustituidas, sus sales, medicamentos que contiene estos compuestos y su empleo, asi como procedimientos para su preparacion.
BR112022019532A2 (pt) Conjugados de neodegrader
UY37580A (es) Compuestos novedosos que inhiben la actividad de cinasa lrrk2
CL2021001488A1 (es) Transposasa de piggybac mutada
BRPI0615614A2 (pt) compostos orgánicos
AR045144A1 (es) Metodo para tratar a un paciente que tiene un neoplasma o que tiene riesgo de desarrollarlo
BR0107928A (pt) Métodos para aumentar a saúde da planta, proteger as plantas de lesões relacionadas ao estresse biótico e estresse abiótico e aumentar a recuperação de plantas lesionadas como consequência de tais estresses
BR0208019A (pt) Fluoralcoxifenilsulfoniluréias substituìdas
BR9912556A (pt) Triazolpiridinas para o tratamento de distúrbios trombóticos
AR013760A1 (es) Oligonucleotidos antisentido contra tenascina para el tratamiento de vitiligo.
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
PA8665701A1 (es) Proceso para la purificacion de compuestos benzoxazol substituidos
BR112022020412A2 (pt) Sequências antissenso para tratar esclerose lateral amiotrófica

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 513316

Country of ref document: ES